- Home
- WRAP vs HOWL Comparison
WRAP vs HOWL Comparison
Compare WRAP & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- HOWL
- Stock Information
- Founded
- WRAP 2016
- HOWL 2017
- Country
- WRAP United States
- HOWL United States
- Employees
- WRAP N/A
- HOWL N/A
- Industry
- WRAP Ordnance And Accessories
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- HOWL Health Care
- Exchange
- WRAP Nasdaq
- HOWL Nasdaq
- Market Cap
- WRAP 73.3M
- HOWL 53.4M
- IPO Year
- WRAP N/A
- HOWL 2021
- Fundamental
- Price
- WRAP $1.41
- HOWL $1.30
- Analyst Decision
- WRAP
- HOWL Strong Buy
- Analyst Count
- WRAP 0
- HOWL 3
- Target Price
- WRAP N/A
- HOWL $8.33
- AVG Volume (30 Days)
- WRAP 169.4K
- HOWL 549.8K
- Earning Date
- WRAP 05-15-2025
- HOWL 08-07-2025
- Dividend Yield
- WRAP N/A
- HOWL N/A
- EPS Growth
- WRAP N/A
- HOWL N/A
- EPS
- WRAP N/A
- HOWL N/A
- Revenue
- WRAP $3,796,000.00
- HOWL $1,143,000.00
- Revenue This Year
- WRAP N/A
- HOWL N/A
- Revenue Next Year
- WRAP N/A
- HOWL N/A
- P/E Ratio
- WRAP N/A
- HOWL N/A
- Revenue Growth
- WRAP N/A
- HOWL N/A
- 52 Week Low
- WRAP $1.30
- HOWL $0.60
- 52 Week High
- WRAP $2.58
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- WRAP 44.98
- HOWL 45.36
- Support Level
- WRAP $1.51
- HOWL $1.03
- Resistance Level
- WRAP $1.60
- HOWL $1.10
- Average True Range (ATR)
- WRAP 0.08
- HOWL 0.07
- MACD
- WRAP -0.01
- HOWL -0.02
- Stochastic Oscillator
- WRAP 23.81
- HOWL 22.81
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.